nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Clonidine—hypertension	0.326	1	CrCtD
Brimonidine—ADRA2B—hypertension	0.12	0.695	CbGaD
Brimonidine—Tizanidine—Clonidine—hypertension	0.108	0.557	CrCrCtD
Brimonidine—Apraclonidine—Clonidine—hypertension	0.0855	0.443	CrCrCtD
Brimonidine—ADRA2A—hypertension	0.0525	0.305	CbGaD
Brimonidine—ADRA2C—Guanabenz—hypertension	0.0181	0.092	CbGbCtD
Brimonidine—ADRA2B—Guanabenz—hypertension	0.0172	0.0873	CbGbCtD
Brimonidine—ADRA2B—Guanfacine—hypertension	0.016	0.0812	CbGbCtD
Brimonidine—ADRA2C—Fenoldopam—hypertension	0.0143	0.0727	CbGbCtD
Brimonidine—ADRA2B—Fenoldopam—hypertension	0.0136	0.069	CbGbCtD
Brimonidine—ADRA2A—Methyldopa—hypertension	0.013	0.0664	CbGbCtD
Brimonidine—ADRA2A—Guanabenz—hypertension	0.0119	0.0607	CbGbCtD
Brimonidine—ADRA2A—Guanfacine—hypertension	0.0111	0.0564	CbGbCtD
Brimonidine—ADRA2B—Prazosin—hypertension	0.0103	0.0523	CbGbCtD
Brimonidine—ADRA2A—Fenoldopam—hypertension	0.00943	0.048	CbGbCtD
Brimonidine—ADRA2C—Carvedilol—hypertension	0.00935	0.0476	CbGbCtD
Brimonidine—ADRA2B—Carvedilol—hypertension	0.00887	0.0451	CbGbCtD
Brimonidine—ADRA2A—Doxazosin—hypertension	0.00871	0.0443	CbGbCtD
Brimonidine—ADRA2C—Clonidine—hypertension	0.00821	0.0418	CbGbCtD
Brimonidine—ADRA2B—Clonidine—hypertension	0.00779	0.0396	CbGbCtD
Brimonidine—ADRA2A—Prazosin—hypertension	0.00715	0.0364	CbGbCtD
Brimonidine—ADRA2A—Carvedilol—hypertension	0.00617	0.0314	CbGbCtD
Brimonidine—ADRA2A—Clonidine—hypertension	0.00542	0.0276	CbGbCtD
Brimonidine—Tizanidine—NISCH—hypertension	0.000532	0.254	CrCbGaD
Brimonidine—Clonidine—NISCH—hypertension	0.00026	0.124	CrCbGaD
Brimonidine—Tizanidine—ADRA2B—hypertension	0.000248	0.118	CrCbGaD
Brimonidine—Apraclonidine—ADRA2B—hypertension	0.000242	0.115	CrCbGaD
Brimonidine—Apraclonidine—ADRA1A—hypertension	0.00015	0.0714	CrCbGaD
Brimonidine—AOX1—nephron tubule—hypertension	0.000136	0.0556	CbGeAlD
Brimonidine—AOX1—adrenal cortex—hypertension	0.000133	0.0547	CbGeAlD
Brimonidine—AOX1—heart—hypertension	0.000129	0.0529	CbGeAlD
Brimonidine—AOX1—decidua—hypertension	0.000125	0.0515	CbGeAlD
Brimonidine—ADRA2C—cardiac ventricle—hypertension	0.000124	0.051	CbGeAlD
Brimonidine—Clonidine—ADRA2B—hypertension	0.000121	0.0578	CrCbGaD
Brimonidine—AOX1—kidney—hypertension	0.000119	0.0489	CbGeAlD
Brimonidine—ADRA2C—myocardium—hypertension	0.000117	0.048	CbGeAlD
Brimonidine—AOX1—cortex of kidney—hypertension	0.000116	0.0476	CbGeAlD
Brimonidine—AOX1—cardiac atrium—hypertension	0.00011	0.0453	CbGeAlD
Brimonidine—Tizanidine—ADRA2A—hypertension	0.000109	0.0519	CrCbGaD
Brimonidine—Clonidine—SLC6A2—hypertension	0.000106	0.0508	CrCbGaD
Brimonidine—Apraclonidine—ADRA2A—hypertension	0.000106	0.0506	CrCbGaD
Brimonidine—AOX1—adrenal gland—hypertension	9.63e-05	0.0395	CbGeAlD
Brimonidine—ADRA2C—nephron tubule—hypertension	8.57e-05	0.0352	CbGeAlD
Brimonidine—ADRA2C—adrenal cortex—hypertension	8.43e-05	0.0346	CbGeAlD
Brimonidine—AOX1—endocrine gland—hypertension	8.35e-05	0.0343	CbGeAlD
Brimonidine—ADRA2C—heart—hypertension	8.15e-05	0.0335	CbGeAlD
Brimonidine—ADRA2C—decidua—hypertension	7.93e-05	0.0326	CbGeAlD
Brimonidine—ADRA2C—kidney—hypertension	7.53e-05	0.0309	CbGeAlD
Brimonidine—Clonidine—ADRA1A—hypertension	7.5e-05	0.0358	CrCbGaD
Brimonidine—ADRA2C—cortex of kidney—hypertension	7.33e-05	0.0301	CbGeAlD
Brimonidine—ADRA2C—cardiac atrium—hypertension	6.97e-05	0.0286	CbGeAlD
Brimonidine—ADRA2C—medulla oblongata—hypertension	6.57e-05	0.027	CbGeAlD
Brimonidine—ADRA2A—heart—hypertension	6.51e-05	0.0267	CbGeAlD
Brimonidine—ADRA2A—decidua—hypertension	6.33e-05	0.026	CbGeAlD
Brimonidine—ADRA2C—adrenal gland—hypertension	6.09e-05	0.025	CbGeAlD
Brimonidine—ADRA2A—cortex of kidney—hypertension	5.85e-05	0.024	CbGeAlD
Brimonidine—Clonidine—CYP3A5—hypertension	5.64e-05	0.0269	CrCbGaD
Brimonidine—ADRA2A—cardiac atrium—hypertension	5.57e-05	0.0228	CbGeAlD
Brimonidine—Clonidine—ADRA2A—hypertension	5.31e-05	0.0253	CrCbGaD
Brimonidine—ADRA2A—medulla oblongata—hypertension	5.25e-05	0.0215	CbGeAlD
Brimonidine—ADRA2A—adrenal gland—hypertension	4.86e-05	0.0199	CbGeAlD
Brimonidine—ADRA2C—central nervous system—hypertension	4.76e-05	0.0195	CbGeAlD
Brimonidine—ADRA2A—endocrine gland—hypertension	4.21e-05	0.0173	CbGeAlD
Brimonidine—Clonidine—CYP1A1—hypertension	3.83e-05	0.0183	CrCbGaD
Brimonidine—ADRA2A—central nervous system—hypertension	3.8e-05	0.0156	CbGeAlD
Brimonidine—Dizziness—Doxazosin—hypertension	1.19e-05	0.000169	CcSEcCtD
Brimonidine—Insomnia—Losartan—hypertension	1.19e-05	0.000168	CcSEcCtD
Brimonidine—Dyspepsia—Betaxolol—hypertension	1.19e-05	0.000168	CcSEcCtD
Brimonidine—Loss of consciousness—Timolol—hypertension	1.19e-05	0.000168	CcSEcCtD
Brimonidine—Pain—Hydrochlorothiazide—hypertension	1.18e-05	0.000168	CcSEcCtD
Brimonidine—Vision blurred—Lisinopril—hypertension	1.18e-05	0.000167	CcSEcCtD
Brimonidine—Paraesthesia—Losartan—hypertension	1.18e-05	0.000167	CcSEcCtD
Brimonidine—Cough—Timolol—hypertension	1.18e-05	0.000167	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Furosemide—hypertension	1.18e-05	0.000167	CcSEcCtD
Brimonidine—Myalgia—Ramipril—hypertension	1.17e-05	0.000167	CcSEcCtD
Brimonidine—Arthralgia—Ramipril—hypertension	1.17e-05	0.000167	CcSEcCtD
Brimonidine—Chest pain—Ramipril—hypertension	1.17e-05	0.000167	CcSEcCtD
Brimonidine—Dizziness—Fosinopril—hypertension	1.17e-05	0.000166	CcSEcCtD
Brimonidine—Fatigue—Furosemide—hypertension	1.17e-05	0.000166	CcSEcCtD
Brimonidine—Dyspnoea—Losartan—hypertension	1.17e-05	0.000166	CcSEcCtD
Brimonidine—Anxiety—Ramipril—hypertension	1.17e-05	0.000166	CcSEcCtD
Brimonidine—Somnolence—Losartan—hypertension	1.17e-05	0.000166	CcSEcCtD
Brimonidine—Dizziness—Eplerenone—hypertension	1.17e-05	0.000165	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	1.17e-05	0.000165	CcSEcCtD
Brimonidine—Asthenia—Valsartan—hypertension	1.17e-05	0.000165	CcSEcCtD
Brimonidine—Hypertension—Timolol—hypertension	1.16e-05	0.000165	CcSEcCtD
Brimonidine—Pain—Furosemide—hypertension	1.16e-05	0.000165	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Betaxolol—hypertension	1.16e-05	0.000165	CcSEcCtD
Brimonidine—Fatigue—Betaxolol—hypertension	1.16e-05	0.000165	CcSEcCtD
Brimonidine—Discomfort—Ramipril—hypertension	1.16e-05	0.000165	CcSEcCtD
Brimonidine—Asthenia—Olmesartan—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Dizziness—Nifedipine—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Rash—Indapamide—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Rash—Diltiazem—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Dermatitis—Diltiazem—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Dermatitis—Indapamide—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Dyspepsia—Losartan—hypertension	1.16e-05	0.000164	CcSEcCtD
Brimonidine—Dizziness—Verapamil—hypertension	1.15e-05	0.000164	CcSEcCtD
Brimonidine—Pain—Betaxolol—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Headache—Indapamide—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Headache—Diltiazem—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Pruritus—Valsartan—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Dry mouth—Ramipril—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Chest pain—Timolol—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Arthralgia—Timolol—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Myalgia—Timolol—hypertension	1.15e-05	0.000163	CcSEcCtD
Brimonidine—Rash—Carvedilol—hypertension	1.15e-05	0.000162	CcSEcCtD
Brimonidine—Dermatitis—Carvedilol—hypertension	1.15e-05	0.000162	CcSEcCtD
Brimonidine—Anxiety—Timolol—hypertension	1.14e-05	0.000162	CcSEcCtD
Brimonidine—Pruritus—Olmesartan—hypertension	1.14e-05	0.000162	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	1.14e-05	0.000162	CcSEcCtD
Brimonidine—Hypersensitivity—Clonidine—hypertension	1.14e-05	0.000162	CcSEcCtD
Brimonidine—Headache—Carvedilol—hypertension	1.14e-05	0.000161	CcSEcCtD
Brimonidine—Discomfort—Timolol—hypertension	1.13e-05	0.000161	CcSEcCtD
Brimonidine—Rash—Doxazosin—hypertension	1.13e-05	0.000161	CcSEcCtD
Brimonidine—Fatigue—Losartan—hypertension	1.13e-05	0.000161	CcSEcCtD
Brimonidine—Dermatitis—Doxazosin—hypertension	1.13e-05	0.000161	CcSEcCtD
Brimonidine—Nausea—Propranolol—hypertension	1.13e-05	0.00016	CcSEcCtD
Brimonidine—Oedema—Ramipril—hypertension	1.13e-05	0.00016	CcSEcCtD
Brimonidine—Headache—Doxazosin—hypertension	1.13e-05	0.00016	CcSEcCtD
Brimonidine—Dry mouth—Timolol—hypertension	1.12e-05	0.000159	CcSEcCtD
Brimonidine—Pain—Losartan—hypertension	1.12e-05	0.000159	CcSEcCtD
Brimonidine—Syncope—Lisinopril—hypertension	1.12e-05	0.000159	CcSEcCtD
Brimonidine—Rash—Fosinopril—hypertension	1.12e-05	0.000159	CcSEcCtD
Brimonidine—Dermatitis—Fosinopril—hypertension	1.12e-05	0.000159	CcSEcCtD
Brimonidine—Rash—Eplerenone—hypertension	1.11e-05	0.000158	CcSEcCtD
Brimonidine—Headache—Fosinopril—hypertension	1.11e-05	0.000158	CcSEcCtD
Brimonidine—Hypersensitivity—Trandolapril—hypertension	1.11e-05	0.000158	CcSEcCtD
Brimonidine—Dermatitis—Eplerenone—hypertension	1.11e-05	0.000158	CcSEcCtD
Brimonidine—Asthenia—Clonidine—hypertension	1.11e-05	0.000157	CcSEcCtD
Brimonidine—Shock—Ramipril—hypertension	1.11e-05	0.000157	CcSEcCtD
Brimonidine—Hypersensitivity—Enalapril—hypertension	1.11e-05	0.000157	CcSEcCtD
Brimonidine—Palpitations—Lisinopril—hypertension	1.11e-05	0.000157	CcSEcCtD
Brimonidine—Headache—Eplerenone—hypertension	1.11e-05	0.000157	CcSEcCtD
Brimonidine—Rash—Nifedipine—hypertension	1.1e-05	0.000157	CcSEcCtD
Brimonidine—Nervous system disorder—Ramipril—hypertension	1.1e-05	0.000157	CcSEcCtD
Brimonidine—Dermatitis—Nifedipine—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Oedema—Timolol—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Loss of consciousness—Lisinopril—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Rash—Verapamil—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Tachycardia—Ramipril—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Dermatitis—Verapamil—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Headache—Nifedipine—hypertension	1.1e-05	0.000156	CcSEcCtD
Brimonidine—Pruritus—Clonidine—hypertension	1.1e-05	0.000155	CcSEcCtD
Brimonidine—Skin disorder—Ramipril—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Infection—Timolol—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Headache—Verapamil—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Hypersensitivity—Telmisartan—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Cough—Lisinopril—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Nausea—Diltiazem—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Nausea—Indapamide—hypertension	1.09e-05	0.000155	CcSEcCtD
Brimonidine—Asthenia—Trandolapril—hypertension	1.08e-05	0.000154	CcSEcCtD
Brimonidine—Shock—Timolol—hypertension	1.08e-05	0.000154	CcSEcCtD
Brimonidine—Nervous system disorder—Timolol—hypertension	1.08e-05	0.000153	CcSEcCtD
Brimonidine—Nausea—Carvedilol—hypertension	1.08e-05	0.000153	CcSEcCtD
Brimonidine—Asthenia—Enalapril—hypertension	1.08e-05	0.000153	CcSEcCtD
Brimonidine—Dizziness—Valsartan—hypertension	1.07e-05	0.000152	CcSEcCtD
Brimonidine—Skin disorder—Timolol—hypertension	1.07e-05	0.000152	CcSEcCtD
Brimonidine—Dizziness—Olmesartan—hypertension	1.07e-05	0.000152	CcSEcCtD
Brimonidine—Pruritus—Trandolapril—hypertension	1.07e-05	0.000151	CcSEcCtD
Brimonidine—Nausea—Doxazosin—hypertension	1.07e-05	0.000151	CcSEcCtD
Brimonidine—Myalgia—Lisinopril—hypertension	1.07e-05	0.000151	CcSEcCtD
Brimonidine—Chest pain—Lisinopril—hypertension	1.07e-05	0.000151	CcSEcCtD
Brimonidine—Arthralgia—Lisinopril—hypertension	1.07e-05	0.000151	CcSEcCtD
Brimonidine—Asthenia—Telmisartan—hypertension	1.06e-05	0.000151	CcSEcCtD
Brimonidine—Pruritus—Enalapril—hypertension	1.06e-05	0.000151	CcSEcCtD
Brimonidine—Anxiety—Lisinopril—hypertension	1.06e-05	0.000151	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.06e-05	0.00015	CcSEcCtD
Brimonidine—Nausea—Fosinopril—hypertension	1.05e-05	0.00015	CcSEcCtD
Brimonidine—Discomfort—Lisinopril—hypertension	1.05e-05	0.000149	CcSEcCtD
Brimonidine—Hypotension—Ramipril—hypertension	1.05e-05	0.000149	CcSEcCtD
Brimonidine—Pruritus—Telmisartan—hypertension	1.05e-05	0.000149	CcSEcCtD
Brimonidine—Nausea—Eplerenone—hypertension	1.05e-05	0.000149	CcSEcCtD
Brimonidine—Dry mouth—Lisinopril—hypertension	1.04e-05	0.000148	CcSEcCtD
Brimonidine—Nausea—Nifedipine—hypertension	1.04e-05	0.000148	CcSEcCtD
Brimonidine—Nausea—Verapamil—hypertension	1.04e-05	0.000147	CcSEcCtD
Brimonidine—Asthenia—Captopril—hypertension	1.03e-05	0.000147	CcSEcCtD
Brimonidine—Hypotension—Timolol—hypertension	1.03e-05	0.000146	CcSEcCtD
Brimonidine—Hypersensitivity—Irbesartan—hypertension	1.03e-05	0.000146	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Ramipril—hypertension	1.03e-05	0.000145	CcSEcCtD
Brimonidine—Rash—Valsartan—hypertension	1.02e-05	0.000145	CcSEcCtD
Brimonidine—Dizziness—Clonidine—hypertension	1.02e-05	0.000145	CcSEcCtD
Brimonidine—Dermatitis—Valsartan—hypertension	1.02e-05	0.000145	CcSEcCtD
Brimonidine—Oedema—Lisinopril—hypertension	1.02e-05	0.000145	CcSEcCtD
Brimonidine—Pruritus—Captopril—hypertension	1.02e-05	0.000145	CcSEcCtD
Brimonidine—Hypersensitivity—Hydrochlorothiazide—hypertension	1.02e-05	0.000145	CcSEcCtD
Brimonidine—Rash—Olmesartan—hypertension	1.02e-05	0.000144	CcSEcCtD
Brimonidine—Insomnia—Ramipril—hypertension	1.02e-05	0.000144	CcSEcCtD
Brimonidine—Dermatitis—Olmesartan—hypertension	1.02e-05	0.000144	CcSEcCtD
Brimonidine—Headache—Valsartan—hypertension	1.02e-05	0.000144	CcSEcCtD
Brimonidine—Infection—Lisinopril—hypertension	1.01e-05	0.000144	CcSEcCtD
Brimonidine—Headache—Olmesartan—hypertension	1.01e-05	0.000144	CcSEcCtD
Brimonidine—Paraesthesia—Ramipril—hypertension	1.01e-05	0.000143	CcSEcCtD
Brimonidine—Shock—Lisinopril—hypertension	1.01e-05	0.000142	CcSEcCtD
Brimonidine—Asthenia—Perindopril—hypertension	1e-05	0.000142	CcSEcCtD
Brimonidine—Dyspnoea—Ramipril—hypertension	1e-05	0.000142	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Timolol—hypertension	1e-05	0.000142	CcSEcCtD
Brimonidine—Hypersensitivity—Furosemide—hypertension	1e-05	0.000142	CcSEcCtD
Brimonidine—Asthenia—Irbesartan—hypertension	1e-05	0.000142	CcSEcCtD
Brimonidine—Somnolence—Ramipril—hypertension	1e-05	0.000142	CcSEcCtD
Brimonidine—Dizziness—Trandolapril—hypertension	9.99e-06	0.000142	CcSEcCtD
Brimonidine—Tachycardia—Lisinopril—hypertension	9.97e-06	0.000141	CcSEcCtD
Brimonidine—Insomnia—Timolol—hypertension	9.96e-06	0.000141	CcSEcCtD
Brimonidine—Dizziness—Enalapril—hypertension	9.95e-06	0.000141	CcSEcCtD
Brimonidine—Asthenia—Hydrochlorothiazide—hypertension	9.93e-06	0.000141	CcSEcCtD
Brimonidine—Hypersensitivity—Betaxolol—hypertension	9.93e-06	0.000141	CcSEcCtD
Brimonidine—Skin disorder—Lisinopril—hypertension	9.92e-06	0.000141	CcSEcCtD
Brimonidine—Dyspepsia—Ramipril—hypertension	9.92e-06	0.000141	CcSEcCtD
Brimonidine—Pruritus—Perindopril—hypertension	9.91e-06	0.00014	CcSEcCtD
Brimonidine—Paraesthesia—Timolol—hypertension	9.89e-06	0.00014	CcSEcCtD
Brimonidine—Pruritus—Irbesartan—hypertension	9.88e-06	0.00014	CcSEcCtD
Brimonidine—Dyspnoea—Timolol—hypertension	9.82e-06	0.000139	CcSEcCtD
Brimonidine—Dizziness—Telmisartan—hypertension	9.81e-06	0.000139	CcSEcCtD
Brimonidine—Pruritus—Hydrochlorothiazide—hypertension	9.79e-06	0.000139	CcSEcCtD
Brimonidine—Somnolence—Timolol—hypertension	9.79e-06	0.000139	CcSEcCtD
Brimonidine—Asthenia—Furosemide—hypertension	9.77e-06	0.000138	CcSEcCtD
Brimonidine—Rash—Clonidine—hypertension	9.76e-06	0.000138	CcSEcCtD
Brimonidine—Dermatitis—Clonidine—hypertension	9.75e-06	0.000138	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Ramipril—hypertension	9.72e-06	0.000138	CcSEcCtD
Brimonidine—Fatigue—Ramipril—hypertension	9.71e-06	0.000138	CcSEcCtD
Brimonidine—Headache—Clonidine—hypertension	9.7e-06	0.000137	CcSEcCtD
Brimonidine—Dyspepsia—Timolol—hypertension	9.69e-06	0.000137	CcSEcCtD
Brimonidine—Hypersensitivity—Losartan—hypertension	9.68e-06	0.000137	CcSEcCtD
Brimonidine—Asthenia—Betaxolol—hypertension	9.67e-06	0.000137	CcSEcCtD
Brimonidine—Nausea—Valsartan—hypertension	9.65e-06	0.000137	CcSEcCtD
Brimonidine—Pruritus—Furosemide—hypertension	9.63e-06	0.000137	CcSEcCtD
Brimonidine—Nausea—Olmesartan—hypertension	9.6e-06	0.000136	CcSEcCtD
Brimonidine—Hypotension—Lisinopril—hypertension	9.55e-06	0.000135	CcSEcCtD
Brimonidine—Dizziness—Captopril—hypertension	9.54e-06	0.000135	CcSEcCtD
Brimonidine—Pruritus—Betaxolol—hypertension	9.54e-06	0.000135	CcSEcCtD
Brimonidine—Rash—Trandolapril—hypertension	9.52e-06	0.000135	CcSEcCtD
Brimonidine—Dermatitis—Trandolapril—hypertension	9.51e-06	0.000135	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Timolol—hypertension	9.51e-06	0.000135	CcSEcCtD
Brimonidine—Fatigue—Timolol—hypertension	9.49e-06	0.000135	CcSEcCtD
Brimonidine—Rash—Enalapril—hypertension	9.48e-06	0.000134	CcSEcCtD
Brimonidine—Dermatitis—Enalapril—hypertension	9.47e-06	0.000134	CcSEcCtD
Brimonidine—Headache—Trandolapril—hypertension	9.46e-06	0.000134	CcSEcCtD
Brimonidine—Asthenia—Losartan—hypertension	9.42e-06	0.000134	CcSEcCtD
Brimonidine—Headache—Enalapril—hypertension	9.42e-06	0.000134	CcSEcCtD
Brimonidine—Pain—Timolol—hypertension	9.42e-06	0.000133	CcSEcCtD
Brimonidine—Rash—Telmisartan—hypertension	9.35e-06	0.000133	CcSEcCtD
Brimonidine—Dermatitis—Telmisartan—hypertension	9.34e-06	0.000132	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Lisinopril—hypertension	9.31e-06	0.000132	CcSEcCtD
Brimonidine—Pruritus—Losartan—hypertension	9.29e-06	0.000132	CcSEcCtD
Brimonidine—Headache—Telmisartan—hypertension	9.29e-06	0.000132	CcSEcCtD
Brimonidine—Dizziness—Perindopril—hypertension	9.26e-06	0.000131	CcSEcCtD
Brimonidine—Insomnia—Lisinopril—hypertension	9.24e-06	0.000131	CcSEcCtD
Brimonidine—Dizziness—Irbesartan—hypertension	9.23e-06	0.000131	CcSEcCtD
Brimonidine—Nausea—Clonidine—hypertension	9.2e-06	0.00013	CcSEcCtD
Brimonidine—Paraesthesia—Lisinopril—hypertension	9.17e-06	0.00013	CcSEcCtD
Brimonidine—Dizziness—Hydrochlorothiazide—hypertension	9.15e-06	0.00013	CcSEcCtD
Brimonidine—Dyspnoea—Lisinopril—hypertension	9.11e-06	0.000129	CcSEcCtD
Brimonidine—Rash—Captopril—hypertension	9.09e-06	0.000129	CcSEcCtD
Brimonidine—Dermatitis—Captopril—hypertension	9.09e-06	0.000129	CcSEcCtD
Brimonidine—Somnolence—Lisinopril—hypertension	9.08e-06	0.000129	CcSEcCtD
Brimonidine—Headache—Captopril—hypertension	9.04e-06	0.000128	CcSEcCtD
Brimonidine—Dizziness—Furosemide—hypertension	9e-06	0.000128	CcSEcCtD
Brimonidine—Dyspepsia—Lisinopril—hypertension	8.99e-06	0.000127	CcSEcCtD
Brimonidine—Nausea—Trandolapril—hypertension	8.97e-06	0.000127	CcSEcCtD
Brimonidine—Nausea—Enalapril—hypertension	8.93e-06	0.000127	CcSEcCtD
Brimonidine—Dizziness—Betaxolol—hypertension	8.91e-06	0.000126	CcSEcCtD
Brimonidine—Rash—Perindopril—hypertension	8.83e-06	0.000125	CcSEcCtD
Brimonidine—Dermatitis—Perindopril—hypertension	8.82e-06	0.000125	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Lisinopril—hypertension	8.82e-06	0.000125	CcSEcCtD
Brimonidine—Nausea—Telmisartan—hypertension	8.81e-06	0.000125	CcSEcCtD
Brimonidine—Fatigue—Lisinopril—hypertension	8.81e-06	0.000125	CcSEcCtD
Brimonidine—Rash—Irbesartan—hypertension	8.8e-06	0.000125	CcSEcCtD
Brimonidine—Dermatitis—Irbesartan—hypertension	8.79e-06	0.000125	CcSEcCtD
Brimonidine—Headache—Perindopril—hypertension	8.77e-06	0.000124	CcSEcCtD
Brimonidine—Headache—Irbesartan—hypertension	8.74e-06	0.000124	CcSEcCtD
Brimonidine—Pain—Lisinopril—hypertension	8.74e-06	0.000124	CcSEcCtD
Brimonidine—Rash—Hydrochlorothiazide—hypertension	8.73e-06	0.000124	CcSEcCtD
Brimonidine—Dermatitis—Hydrochlorothiazide—hypertension	8.72e-06	0.000124	CcSEcCtD
Brimonidine—Dizziness—Losartan—hypertension	8.69e-06	0.000123	CcSEcCtD
Brimonidine—Headache—Hydrochlorothiazide—hypertension	8.67e-06	0.000123	CcSEcCtD
Brimonidine—Rash—Furosemide—hypertension	8.58e-06	0.000122	CcSEcCtD
Brimonidine—Dermatitis—Furosemide—hypertension	8.58e-06	0.000122	CcSEcCtD
Brimonidine—Nausea—Captopril—hypertension	8.57e-06	0.000121	CcSEcCtD
Brimonidine—Headache—Furosemide—hypertension	8.53e-06	0.000121	CcSEcCtD
Brimonidine—Rash—Betaxolol—hypertension	8.5e-06	0.00012	CcSEcCtD
Brimonidine—Dermatitis—Betaxolol—hypertension	8.49e-06	0.00012	CcSEcCtD
Brimonidine—Headache—Betaxolol—hypertension	8.44e-06	0.00012	CcSEcCtD
Brimonidine—Nausea—Perindopril—hypertension	8.32e-06	0.000118	CcSEcCtD
Brimonidine—Hypersensitivity—Ramipril—hypertension	8.3e-06	0.000118	CcSEcCtD
Brimonidine—Nausea—Irbesartan—hypertension	8.29e-06	0.000118	CcSEcCtD
Brimonidine—Rash—Losartan—hypertension	8.28e-06	0.000117	CcSEcCtD
Brimonidine—Dermatitis—Losartan—hypertension	8.28e-06	0.000117	CcSEcCtD
Brimonidine—Headache—Losartan—hypertension	8.23e-06	0.000117	CcSEcCtD
Brimonidine—Nausea—Hydrochlorothiazide—hypertension	8.22e-06	0.000117	CcSEcCtD
Brimonidine—Hypersensitivity—Timolol—hypertension	8.11e-06	0.000115	CcSEcCtD
Brimonidine—Nausea—Furosemide—hypertension	8.09e-06	0.000115	CcSEcCtD
Brimonidine—Asthenia—Ramipril—hypertension	8.08e-06	0.000115	CcSEcCtD
Brimonidine—Nausea—Betaxolol—hypertension	8.01e-06	0.000114	CcSEcCtD
Brimonidine—Pruritus—Ramipril—hypertension	7.97e-06	0.000113	CcSEcCtD
Brimonidine—Asthenia—Timolol—hypertension	7.9e-06	0.000112	CcSEcCtD
Brimonidine—Nausea—Losartan—hypertension	7.8e-06	0.000111	CcSEcCtD
Brimonidine—Pruritus—Timolol—hypertension	7.79e-06	0.00011	CcSEcCtD
Brimonidine—Hypersensitivity—Lisinopril—hypertension	7.53e-06	0.000107	CcSEcCtD
Brimonidine—Dizziness—Ramipril—hypertension	7.45e-06	0.000106	CcSEcCtD
Brimonidine—Asthenia—Lisinopril—hypertension	7.33e-06	0.000104	CcSEcCtD
Brimonidine—Dizziness—Timolol—hypertension	7.28e-06	0.000103	CcSEcCtD
Brimonidine—Pruritus—Lisinopril—hypertension	7.23e-06	0.000102	CcSEcCtD
Brimonidine—Rash—Ramipril—hypertension	7.1e-06	0.000101	CcSEcCtD
Brimonidine—Dermatitis—Ramipril—hypertension	7.1e-06	0.000101	CcSEcCtD
Brimonidine—Headache—Ramipril—hypertension	7.06e-06	0.0001	CcSEcCtD
Brimonidine—Rash—Timolol—hypertension	6.94e-06	9.84e-05	CcSEcCtD
Brimonidine—Dermatitis—Timolol—hypertension	6.94e-06	9.83e-05	CcSEcCtD
Brimonidine—Headache—Timolol—hypertension	6.9e-06	9.78e-05	CcSEcCtD
Brimonidine—Dizziness—Lisinopril—hypertension	6.76e-06	9.58e-05	CcSEcCtD
Brimonidine—Nausea—Ramipril—hypertension	6.69e-06	9.48e-05	CcSEcCtD
Brimonidine—Nausea—Timolol—hypertension	6.54e-06	9.27e-05	CcSEcCtD
Brimonidine—Rash—Lisinopril—hypertension	6.44e-06	9.13e-05	CcSEcCtD
Brimonidine—Dermatitis—Lisinopril—hypertension	6.43e-06	9.12e-05	CcSEcCtD
Brimonidine—Headache—Lisinopril—hypertension	6.4e-06	9.07e-05	CcSEcCtD
Brimonidine—Nausea—Lisinopril—hypertension	6.07e-06	8.6e-05	CcSEcCtD
Brimonidine—ADRA2C—Signaling Pathways—CCL5—hypertension	1.73e-06	4.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOB—hypertension	1.72e-06	4.73e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KL—hypertension	1.72e-06	4.71e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOTCH2—hypertension	1.72e-06	4.71e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NGF—hypertension	1.72e-06	4.71e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SPP1—hypertension	1.72e-06	4.71e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCL8—hypertension	1.71e-06	4.69e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TP53—hypertension	1.71e-06	4.68e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CALM1—hypertension	1.71e-06	4.67e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOE—hypertension	1.7e-06	4.66e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LPL—hypertension	1.7e-06	4.64e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NGFR—hypertension	1.69e-06	4.63e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ITGAV—hypertension	1.69e-06	4.63e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB1—hypertension	1.69e-06	4.62e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KNG1—hypertension	1.68e-06	4.61e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CAV1—hypertension	1.68e-06	4.61e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—H2AFX—hypertension	1.68e-06	4.61e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RPS6KB1—hypertension	1.68e-06	4.6e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PDGFRB—hypertension	1.68e-06	4.6e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOA1—hypertension	1.68e-06	4.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—POMC—hypertension	1.68e-06	4.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTM1—hypertension	1.68e-06	4.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGTR1—hypertension	1.67e-06	4.59e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRL—hypertension	1.67e-06	4.59e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCR5—hypertension	1.67e-06	4.58e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCD—hypertension	1.67e-06	4.58e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADCY5—hypertension	1.66e-06	4.55e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—STK11—hypertension	1.65e-06	4.52e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HDAC1—hypertension	1.65e-06	4.52e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCG—hypertension	1.65e-06	4.52e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—LPL—hypertension	1.65e-06	4.51e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL2—hypertension	1.64e-06	4.5e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ITGB3—hypertension	1.64e-06	4.49e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCA—hypertension	1.64e-06	4.49e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—hypertension	1.64e-06	4.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL10—hypertension	1.64e-06	4.48e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—C3—hypertension	1.63e-06	4.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLG—hypertension	1.63e-06	4.47e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—RHOA—hypertension	1.63e-06	4.46e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—YWHAZ—hypertension	1.62e-06	4.45e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AKT2—hypertension	1.61e-06	4.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ADCY5—hypertension	1.61e-06	4.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PIK3R1—hypertension	1.61e-06	4.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GPX1—hypertension	1.61e-06	4.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NGF—hypertension	1.61e-06	4.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SPP1—hypertension	1.61e-06	4.4e-05	CbGpPWpGaD
Brimonidine—AOX1—Disease—AKT1—hypertension	1.6e-06	4.39e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCL8—hypertension	1.6e-06	4.38e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PDGFB—hypertension	1.59e-06	4.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PRKCA—hypertension	1.59e-06	4.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP1A1—hypertension	1.59e-06	4.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADRB2—hypertension	1.59e-06	4.35e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FGFR1—hypertension	1.58e-06	4.33e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCE—hypertension	1.57e-06	4.3e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CD36—hypertension	1.56e-06	4.29e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCD—hypertension	1.56e-06	4.28e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCR5—hypertension	1.56e-06	4.28e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HIF1A—hypertension	1.56e-06	4.27e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AGT—hypertension	1.55e-06	4.25e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VAV3—hypertension	1.55e-06	4.24e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PDGFA—hypertension	1.55e-06	4.24e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—AKT1—hypertension	1.55e-06	4.23e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—hypertension	1.53e-06	4.19e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CALM1—hypertension	1.53e-06	4.18e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFBR2—hypertension	1.53e-06	4.18e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—C3—hypertension	1.53e-06	4.18e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LEP—hypertension	1.52e-06	4.17e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOE—hypertension	1.52e-06	4.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GNB3—hypertension	1.51e-06	4.14e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CAV1—hypertension	1.51e-06	4.13e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOA1—hypertension	1.5e-06	4.12e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AVP—hypertension	1.49e-06	4.09e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KDR—hypertension	1.49e-06	4.08e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PDGFB—hypertension	1.49e-06	4.07e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—MTHFR—hypertension	1.48e-06	4.06e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARG—hypertension	1.48e-06	4.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—RHOA—hypertension	1.48e-06	4.05e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FGFR1—hypertension	1.48e-06	4.05e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GNAS—hypertension	1.47e-06	4.03e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PIK3R1—hypertension	1.46e-06	4.01e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—POMC—hypertension	1.46e-06	4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HIF1A—hypertension	1.46e-06	3.99e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARA—hypertension	1.45e-06	3.99e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—INS—hypertension	1.45e-06	3.98e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AGT—hypertension	1.45e-06	3.97e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—AKT1—hypertension	1.44e-06	3.95e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOB—hypertension	1.44e-06	3.95e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PTK2—hypertension	1.44e-06	3.94e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FN1—hypertension	1.43e-06	3.93e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—F2—hypertension	1.43e-06	3.93e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCB—hypertension	1.43e-06	3.93e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCL8—hypertension	1.43e-06	3.92e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CALM1—hypertension	1.43e-06	3.91e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LEP—hypertension	1.42e-06	3.89e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOE—hypertension	1.42e-06	3.89e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EDN1—hypertension	1.42e-06	3.89e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AGT—hypertension	1.41e-06	3.86e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL5—hypertension	1.41e-06	3.86e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CAV1—hypertension	1.41e-06	3.86e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOA1—hypertension	1.4e-06	3.85e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOTCH1—hypertension	1.4e-06	3.85e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KDR—hypertension	1.39e-06	3.81e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TP53—hypertension	1.39e-06	3.8e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CALM1—hypertension	1.39e-06	3.8e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOE—hypertension	1.38e-06	3.78e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LPL—hypertension	1.38e-06	3.77e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CAV1—hypertension	1.37e-06	3.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—H2AFX—hypertension	1.37e-06	3.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PDGFRB—hypertension	1.36e-06	3.74e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	1.36e-06	3.74e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOA1—hypertension	1.36e-06	3.74e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADCY5—hypertension	1.35e-06	3.69e-05	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—AKT1—hypertension	1.34e-06	3.68e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FN1—hypertension	1.34e-06	3.67e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCB—hypertension	1.34e-06	3.67e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—F2—hypertension	1.34e-06	3.67e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCG—hypertension	1.34e-06	3.67e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—hypertension	1.33e-06	3.65e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ITGB3—hypertension	1.33e-06	3.64e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCA—hypertension	1.33e-06	3.64e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	1.32e-06	3.61e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOTCH1—hypertension	1.31e-06	3.59e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—POMC—hypertension	1.31e-06	3.58e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NGF—hypertension	1.3e-06	3.57e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SPP1—hypertension	1.3e-06	3.57e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—INS—hypertension	1.3e-06	3.56e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	1.3e-06	3.56e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL2—hypertension	1.28e-06	3.5e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—NOS3—hypertension	1.27e-06	3.49e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PIK3R1—hypertension	1.27e-06	3.49e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCD—hypertension	1.27e-06	3.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR5—hypertension	1.27e-06	3.48e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF1—hypertension	1.26e-06	3.44e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT2—hypertension	1.26e-06	3.44e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—EGFR—hypertension	1.25e-06	3.43e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—hypertension	1.24e-06	3.4e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—C3—hypertension	1.24e-06	3.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—POMC—hypertension	1.22e-06	3.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—INS—hypertension	1.21e-06	3.33e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.21e-06	3.31e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARG—hypertension	1.2e-06	3.29e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.2e-06	3.29e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL2—hypertension	1.19e-06	3.27e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SERPINE1—hypertension	1.19e-06	3.27e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—POMC—hypertension	1.19e-06	3.25e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.18e-06	3.24e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—INS—hypertension	1.18e-06	3.23e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGT—hypertension	1.18e-06	3.23e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF1—hypertension	1.17e-06	3.22e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT2—hypertension	1.17e-06	3.21e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—AKT1—hypertension	1.17e-06	3.21e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—EGFR—hypertension	1.17e-06	3.2e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—hypertension	1.16e-06	3.19e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CALM1—hypertension	1.16e-06	3.17e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FGF2—hypertension	1.16e-06	3.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LEP—hypertension	1.15e-06	3.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOE—hypertension	1.15e-06	3.16e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RHOA—hypertension	1.15e-06	3.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CAV1—hypertension	1.14e-06	3.13e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOA1—hypertension	1.14e-06	3.13e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PIK3R1—hypertension	1.14e-06	3.12e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOS3—hypertension	1.14e-06	3.12e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KDR—hypertension	1.13e-06	3.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SERPINE1—hypertension	1.12e-06	3.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—F2—hypertension	1.09e-06	2.98e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FN1—hypertension	1.09e-06	2.98e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.09e-06	2.98e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—hypertension	1.08e-06	2.96e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FGF2—hypertension	1.08e-06	2.96e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RHOA—hypertension	1.08e-06	2.95e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RELA—hypertension	1.07e-06	2.94e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.07e-06	2.92e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PIK3R1—hypertension	1.06e-06	2.92e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOS3—hypertension	1.06e-06	2.92e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MTOR—hypertension	1.05e-06	2.88e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PIK3R1—hypertension	1.03e-06	2.83e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—NOS3—hypertension	1.03e-06	2.83e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTEN—hypertension	1.02e-06	2.78e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL8—hypertension	1.01e-06	2.77e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RELA—hypertension	1e-06	2.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—POMC—hypertension	9.92e-07	2.72e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—INS—hypertension	9.86e-07	2.7e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MTOR—hypertension	9.83e-07	2.69e-05	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—AKT1—hypertension	9.77e-07	2.68e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL2—hypertension	9.7e-07	2.66e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—EP300—hypertension	9.69e-07	2.65e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—hypertension	9.61e-07	2.63e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF1—hypertension	9.54e-07	2.61e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT2—hypertension	9.53e-07	2.61e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—EGFR—hypertension	9.49e-07	2.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—hypertension	9.46e-07	2.59e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL8—hypertension	9.44e-07	2.59e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—hypertension	9.14e-07	2.51e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—AKT1—hypertension	9.12e-07	2.5e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CDKN1A—hypertension	9.11e-07	2.5e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PTEN—hypertension	9.09e-07	2.49e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	9.06e-07	2.48e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—hypertension	8.98e-07	2.46e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK8—hypertension	8.89e-07	2.44e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AKT1—hypertension	8.87e-07	2.43e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FGF2—hypertension	8.77e-07	2.4e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RHOA—hypertension	8.74e-07	2.39e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EP300—hypertension	8.67e-07	2.38e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	8.65e-07	2.37e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOS3—hypertension	8.65e-07	2.37e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—hypertension	8.54e-07	2.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CDKN1A—hypertension	8.51e-07	2.33e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PTEN—hypertension	8.49e-07	2.33e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SRC—hypertension	8.43e-07	2.31e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK8—hypertension	8.31e-07	2.28e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AKT1—hypertension	8.28e-07	2.27e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTEN—hypertension	8.25e-07	2.26e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—hypertension	8.21e-07	2.25e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RELA—hypertension	8.14e-07	2.23e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EP300—hypertension	8.1e-07	2.22e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MTOR—hypertension	7.98e-07	2.19e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SRC—hypertension	7.88e-07	2.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—EP300—hypertension	7.87e-07	2.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL8—hypertension	7.67e-07	2.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—hypertension	7.67e-07	2.1e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MYC—hypertension	7.56e-07	2.07e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFB1—hypertension	7.54e-07	2.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	7.41e-07	2.03e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EGFR—hypertension	7.39e-07	2.02e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—hypertension	7.29e-07	2e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MYC—hypertension	7.06e-07	1.93e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFB1—hypertension	7.04e-07	1.93e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—hypertension	6.94e-07	1.9e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	6.91e-07	1.89e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EGFR—hypertension	6.9e-07	1.89e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PTEN—hypertension	6.9e-07	1.89e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK8—hypertension	6.75e-07	1.85e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AKT1—hypertension	6.73e-07	1.84e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EP300—hypertension	6.58e-07	1.8e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SRC—hypertension	6.4e-07	1.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—hypertension	6.23e-07	1.71e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TP53—hypertension	6.2e-07	1.7e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AKT1—hypertension	5.85e-07	1.6e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TP53—hypertension	5.8e-07	1.59e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MYC—hypertension	5.73e-07	1.57e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFB1—hypertension	5.72e-07	1.57e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—hypertension	5.68e-07	1.56e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EGFR—hypertension	5.61e-07	1.54e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—hypertension	5.31e-07	1.45e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT1—hypertension	5.24e-07	1.44e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT1—hypertension	4.89e-07	1.34e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AKT1—hypertension	4.75e-07	1.3e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TP53—hypertension	4.71e-07	1.29e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—hypertension	4.31e-07	1.18e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT1—hypertension	3.98e-07	1.09e-05	CbGpPWpGaD
